Patient Leaflet Updated 26-Jan-2024 | SANOFI Consumer Healthcare
Telfast 180mg film-coated tablets
TELFAST 180 mg film-coated tablets
Fexofenadine hydrochloride
Is this leaflet hard to see or read?
In the UK Phone 0800 035 2525 for help
1. What Telfast is and what it is used for
2. What you need to know before you take Telfast
3. How to take Telfast
4. Possible side effects
5. How to store Telfast
6. Contents of the pack and other information
Telfast contains fexofenadine hydrochloride, which is a non-drowsy antihistamine.
Telfast 180 mg is used in adults and adolescents of 12 years and older to relieve the symptoms that occur with long term allergic skin reactions (chronic idiopathic urticaria) such as itching, swelling and rashes.
Talk to your doctor or pharmacist before taking Telfast if:
If any of these apply to you, or if you are not sure, tell your doctor before taking Telfast.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
If you are taking apalutamide (a medicine to treat prostate cancer), as the effect of fexofenadine may be decreased.
Indigestion remedies containing aluminium and magnesium may affect the action of Telfast by lowering the amount of medicinal product absorbed.
It is recommended that you leave about 2 hours between the time that you take Telfast and your indigestion remedy.
Ask your doctor or pharmacist for advice before taking any medicine.
Do not take Telfast if you are pregnant, unless necessary.
Telfast is not recommended during breast-feeding.
Telfast is unlikely to affect your ability to drive or operate machinery. However, you should check that these tablets do not make you feel sleepy or dizzy before driving or operating machinery.
Telfast contains sodium
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially 'sodium-free'
Always take this medicine exactly as your doctor has told you.
Check with your doctor or pharmacist if you are not sure.
The recommended dose is one tablet (180 mg) daily.
Take your tablet with water before a meal.
This medicine starts to relieve your symptoms within 1 hour and lasts for 24 hours.
If you take too many tablets, contact your doctor or the nearest hospital emergency department immediately.
Symptoms of an overdose in adults are dizziness, drowsiness, fatigue and dry mouth.
Do not take a double dose to make up for a forgotten tablet.
Take the next dose at the usual time as prescribed by your doctor.
Tell your doctor if you want to stop taking Telfast before you have finished your course of treatment.
If you stop taking Telfast earlier than planned, your symptoms may return.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following undesirable effects have been reported in clinical trials, with an incidence similar to those observed in patient who did not receive the drug (placebo).
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Additional side effects (frequency not known: cannot be estimated from the available data) which may occur are:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage condition.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Telfast 180 mg film-coated tablets are peach coloured, capsule shaped tablets marked with "018" on one side and a scripted "e" on the other.
Telfast is presented in blister packs. Each tablet is blistered.
Telfast is available in packs of 2 (sample only), 10, 15, 20, 30, 50, 100 and 200 (as 10x20) tablets per package.
Not all pack sizes are marketed.
Marketing Authorisation Holder:
Manufacturer
This medicinal product is authorised in the Member States of the EEA under the following names:
Belgium: Telfast 180 mg filmomhulde tabletten
Denmark: Telfast, filmovertrukne tabletter 180 mg
Finland: Telfast 180 mg tabletti, kalvopäällysteinen
Germany: Telfast 180 mg
Ireland: Telfast 180 mg film coated tablets
Italy: Telfast 180 mg compresse rivestite con film
Luxembourg: Telfast 180 mg filmomhulde tabletten
Malta: Telfast 180 mg film-coated tablets
Portugal: Telfast 180, comprimidos revestidos por película
Spain: Fexofenadina Opella 180 mg comprimidos recubiertos con película
Sweden: Telfast 180 mg filmdragerade tabletter
United Kingdom: Telfast 180 mg film coated tablets
This leaflet was last revised in 07/2023
© Sanofi, 1996 — 2023
882031
410, Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
+44 (0)800 035 2525